UBI please.
I do a technical scan for this competition (when I have time and remember to enter). UBI came up. I don't know much about them. They are a small biotech R&D company, market cap of $40m. Their last report states they had $19m cash, $15 drawn down debt. They have developed and manufacture an instrument that tests blood glucose for use by people with diabetes (marketed globally by Johnson & Johnson) and a blood coagulation testing instrument for monitoring patients using warfarin (marketed by Siemens). They've just launched a new blood glucose testing instrument.
Technically, the share price looks like it has turned around and has just broken through the 200 day moving average. Let's see where it goes in February.